Form 144: Proposed sale of 24,000 shares reported

Filer submitted a Form 144 reporting a proposed sale of common shares.

Rhea-AI Filing Summary

Filer submitted a Form 144 reporting a proposed sale of common shares. The filing lists 24,000 shares alongside an amount of $5,616,932.53 and a figure of 86,963,000 tied to the record line, with an 03/02/2026 date and NYSE designation. The securities listed relate to restricted stock vesting on 02/24/2026, 02/27/2026, 02/28/2026, and 03/01/2026

Insights

Securities Transaction Counsel

Form 144 reports a proposed resale of restricted common shares tied to recent vesting events.

The filing lists 24,000 shares and an amount of $5,616,932.53, and shows restricted stock vesting on 02/24/2026, 02/27/2026, 02/28/2026, and 03/01/2026

Timing and execution depend on market and Rule 144 conditions; subsequent filings or confirmations will show whether these proposed sales occurred.

FAQ

What does the Form 144 for THC report?

The Form 144 reports a proposed sale of common shares, listing 24,000 shares and an amount of $5,616,932.53. It also shows restricted stock vesting on multiple dates in February and March 2026.

Who is listed as the broker or filing agent on the THC Form 144?

The filing lists Fidelity Brokerage Services LLC with an address in Smithfield, RI. This identifies the brokerage entry shown on the form rather than confirming a completed sale.

Are the securities in the filing restricted or vested for THC?

The filing entries are described as Restricted Stock Vesting with specific vesting dates: 02/24/2026, 02/27/2026, 02/28/2026, and 03/01/2026.

Does the Form 144 confirm the sales were completed?

No. The Form 144 reports a proposed resale under applicable rules. Whether the sales were executed is not confirmed in the excerpt; later transaction reports would show completed sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 03:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001852128
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	Arnst Thomas W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	24000	5616932.53	86963000	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2026	Restricted Stock Vesting	Issuer			2304	02/24/2026	Compensation
Common	02/27/2026	Restricted Stock Vesting	Issuer			7638	02/27/2026	Compensation
Common	02/28/2026	Restricted Stock Vesting	Issuer			11037	02/28/2026	Compensation
Common	03/01/2026	Restricted Stock Vesting	Issuer			3021	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey McMillen, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas Arnst
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)